These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 35240899)

  • 1. Malaria transmission blocking compounds: a patent review.
    Consalvi S; Tammaro C; Appetecchia F; Biava M; Poce G
    Expert Opin Ther Pat; 2022 Jun; 32(6):649-666. PubMed ID: 35240899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategic use of antimalarial drugs that block falciparum malaria parasite transmission to mosquitoes to achieve local malaria elimination.
    Abdul-Ghani R; Beier JC
    Parasitol Res; 2014 Oct; 113(10):3535-46. PubMed ID: 25185662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmission-blocking drugs for malaria elimination.
    Birkholtz LM; Alano P; Leroy D
    Trends Parasitol; 2022 May; 38(5):390-403. PubMed ID: 35190283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium falciparum gametocytes: with a view to a kill.
    Butterworth AS; Skinner-Adams TS; Gardiner DL; Trenholme KR
    Parasitology; 2013 Dec; 140(14):1718-34. PubMed ID: 23953486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimalarial drugs: what's new in the patents?
    Lopes EA; Santos MMM; Mori M
    Expert Opin Ther Pat; 2023 Mar; 33(3):151-168. PubMed ID: 37060305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapt or Die: Targeting Unique Transmission-Stage Biology for Malaria Elimination.
    van der Watt ME; Reader J; Birkholtz LM
    Front Cell Infect Microbiol; 2022; 12():901971. PubMed ID: 35755845
    [No Abstract]   [Full Text] [Related]  

  • 8. A class of tricyclic compounds blocking malaria parasite oocyst development and transmission.
    Eastman RT; Pattaradilokrat S; Raj DK; Dixit S; Deng B; Miura K; Yuan J; Tanaka TQ; Johnson RL; Jiang H; Huang R; Williamson KC; Lambert LE; Long C; Austin CP; Wu Y; Su XZ
    Antimicrob Agents Chemother; 2013 Jan; 57(1):425-35. PubMed ID: 23129054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Population biology and antimalarial resistance: The transmission of antimalarial drug resistance in Plasmodium falciparum.
    Barnes KI; White NJ
    Acta Trop; 2005 Jun; 94(3):230-40. PubMed ID: 15878154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Set of Chemical Starting Points with Plasmodium falciparum Transmission-Blocking Potential for Antimalarial Drug Discovery.
    Almela MJ; Lozano S; Lelièvre J; Colmenarejo G; Coterón JM; Rodrigues J; Gonzalez C; Herreros E
    PLoS One; 2015; 10(8):e0135139. PubMed ID: 26317851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small molecule anti-malarial patents: a review (January 2010-June 2011).
    Svennas KL; Macdonald SJ; Willis PA
    Expert Opin Ther Pat; 2012 Jun; 22(6):607-43. PubMed ID: 22694759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. That was then but this is now: malaria research in the time of an eradication agenda.
    Kappe SH; Vaughan AM; Boddey JA; Cowman AF
    Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of melatonin derivatives on human malaria parasite Plasmodium falciparum.
    Srinivasan V; Zakaria R; Mohamed M; Saleh RM
    Recent Pat Endocr Metab Immune Drug Discov; 2014; 8(2):102-8. PubMed ID: 24935182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SnapShot: Antimalarial Drugs.
    Luth MR; Winzeler EA
    Cell; 2020 Oct; 183(2):554-554.e1. PubMed ID: 33064992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites.
    Delves M; Plouffe D; Scheurer C; Meister S; Wittlin S; Winzeler EA; Sinden RE; Leroy D
    PLoS Med; 2012 Feb; 9(2):e1001169. PubMed ID: 22363211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
    Penna-Coutinho J; da Silva Araújo M; Campos Aguiar AC; Sá PM; Rios CT; Medeiros JF; Pereira DB; Boechat N; Krettli AU
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():150-155. PubMed ID: 34637981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology and infectivity of Plasmodium falciparum and Plasmodium vivax gametocytes in relation to malaria control and elimination.
    Bousema T; Drakeley C
    Clin Microbiol Rev; 2011 Apr; 24(2):377-410. PubMed ID: 21482730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovering New Transmission-Blocking Antimalarial Compounds: Challenges and Opportunities.
    Birkholtz LM; Coetzer TL; Mancama D; Leroy D; Alano P
    Trends Parasitol; 2016 Sep; 32(9):669-681. PubMed ID: 27209388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel Transmission-Blocking Antimalarials Identified by High-Throughput Screening of Plasmodium berghei Ookluc.
    Calit J; Araújo JE; Deng B; Miura K; Gaitán XA; Araújo MDS; Medeiros JF; Long CA; Simeonov A; Eastman RT; Bargieri DY
    Antimicrob Agents Chemother; 2023 Apr; 67(4):e0146522. PubMed ID: 36856421
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primaquine for reducing Plasmodium falciparum transmission.
    Graves PM; Gelband H; Garner P
    Cochrane Database Syst Rev; 2012 Sep; (9):CD008152. PubMed ID: 22972117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.